SE9502936L - Antisekretorisk faktor-proteiner som reglerar förändringar i tarmpermeabilitet - Google Patents

Antisekretorisk faktor-proteiner som reglerar förändringar i tarmpermeabilitet

Info

Publication number
SE9502936L
SE9502936L SE9502936A SE9502936A SE9502936L SE 9502936 L SE9502936 L SE 9502936L SE 9502936 A SE9502936 A SE 9502936A SE 9502936 A SE9502936 A SE 9502936A SE 9502936 L SE9502936 L SE 9502936L
Authority
SE
Sweden
Prior art keywords
homologues
fragments
intestinal permeability
protein
factor proteins
Prior art date
Application number
SE9502936A
Other languages
Unknown language ( )
English (en)
Other versions
SE508609C2 (sv
SE9502936D0 (sv
Inventor
Ivar Loennroth
Stefan Lange
Eva Johansson
Eva Jennische
Christina Loennroth
Original Assignee
Nectin Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nectin Ab filed Critical Nectin Ab
Priority to SE9502936A priority Critical patent/SE508609C2/sv
Publication of SE9502936D0 publication Critical patent/SE9502936D0/sv
Priority to RO98-00364A priority patent/RO120197B1/ro
Priority to JP51018597A priority patent/JP4040679B2/ja
Priority to BR9610308-6A priority patent/BR9610308A/pt
Priority to NZ316647A priority patent/NZ316647A/en
Priority to TR1998/00304T priority patent/TR199800304T1/xx
Priority to SK236-98A priority patent/SK23698A3/sk
Priority to CZ1998520A priority patent/CZ295444B6/cs
Priority to PL96325114A priority patent/PL188530B1/pl
Priority to AT96929619T priority patent/ATE270305T1/de
Priority to DK96929619T priority patent/DK0851876T3/da
Priority to KR1019980701343A priority patent/KR100552947B1/ko
Priority to AU68932/96A priority patent/AU702589B2/en
Priority to CNB961973005A priority patent/CN1171902C/zh
Priority to SI9630013T priority patent/SI0851876T1/xx
Priority to PT96929619T priority patent/PT851876E/pt
Priority to DE0851876T priority patent/DE851876T1/de
Priority to HU9900137A priority patent/HU224971B1/hu
Priority to EE9800055A priority patent/EE04501B1/xx
Priority to EA199800221A priority patent/EA001201B1/ru
Priority to US09/029,333 priority patent/US6344440B1/en
Priority to ES96929619T priority patent/ES2118683T3/es
Priority to IL15290996A priority patent/IL152909A0/xx
Priority to CA2230111A priority patent/CA2230111C/en
Priority to DE69632828T priority patent/DE69632828T2/de
Priority to IL12340496A priority patent/IL123404A/xx
Priority to EP96929619A priority patent/EP0851876B1/en
Priority to PCT/SE1996/001049 priority patent/WO1997008202A1/en
Publication of SE9502936L publication Critical patent/SE9502936L/sv
Priority to NO19980743A priority patent/NO320560B1/no
Priority to BG102280A priority patent/BG63209B1/bg
Publication of SE508609C2 publication Critical patent/SE508609C2/sv
Priority to HK99103574A priority patent/HK1018468A1/xx
Priority to NZ337380A priority patent/NZ337380A/en
Priority to US09/991,792 priority patent/US20020099016A1/en
Priority to JP2007193054A priority patent/JP2008043331A/ja

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/40—Mineralocorticosteroids, e.g. aldosterone; Drugs increasing or potentiating the activity of mineralocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Polymers & Plastics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Addiction (AREA)
  • Obesity (AREA)
  • Food Science & Technology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Animal Husbandry (AREA)
SE9502936A 1995-08-24 1995-08-24 Antisekretorisk faktor - dess aminosyrasekvens, nubleinsyrasekvens och användning SE508609C2 (sv)

Priority Applications (34)

Application Number Priority Date Filing Date Title
SE9502936A SE508609C2 (sv) 1995-08-24 1995-08-24 Antisekretorisk faktor - dess aminosyrasekvens, nubleinsyrasekvens och användning
PCT/SE1996/001049 WO1997008202A1 (en) 1995-08-24 1996-08-23 Antisecretory factor peptides regulating pathological permeability changes
DE0851876T DE851876T1 (de) 1995-08-24 1996-08-23 Peptide des antisekretonischen faktors, welches krankhafte permeabilitätsanderungen reguliert
EE9800055A EE04501B1 (et) 1995-08-24 1996-08-23 Patoloogilisi permeaabluse muutusi reguleerivad antisekretoorsed peptiidfaktorid
BR9610308-6A BR9610308A (pt) 1995-08-24 1996-08-23 Peptídios de fator anti-secretório reguladores de alterações de permeabilidade patológica
JP51018597A JP4040679B2 (ja) 1995-08-24 1996-08-23 病理学的浸透性の変化を調節する抗分泌性因子ペプチド
TR1998/00304T TR199800304T1 (xx) 1995-08-24 1996-08-23 Patolojik ge�irgenlik de�i�ikliklerini d�zenleyen anti-salg�sal fakt�r peptidleri.
EA199800221A EA001201B1 (ru) 1995-08-24 1996-08-23 Пептиды антисекреторного фактора, регулирующие патологические изменения проницаемости
CZ1998520A CZ295444B6 (cs) 1995-08-24 1996-08-23 Rekombinantní protein, protilátka, kompozice a krmivo pro normalizaci patologického transportu tekutin a/nebo zánětlivých reakcí, nukleová kyselina, vektor a rekombinantní organismus
PL96325114A PL188530B1 (pl) 1995-08-24 1996-08-23 Rekombinowane białko, peptyd, przeciwciała specyficzne wobec białka, kompozycja farmaceutyczna, zastosowanie rekombinowanego białka, preparat paszowo-weterynaryjny, zastosowanie specyficznych przeciwciał, kwasy nukleinowe, zastosowanie sond lub primerów, wektor i komórka gospodarza
AT96929619T ATE270305T1 (de) 1995-08-24 1996-08-23 Peptide des antisekretorischen faktors, welches krankhafte permeabilitätsanderungen reguliert
DK96929619T DK0851876T3 (da) 1995-08-24 1996-08-23 Antisekretorisk faktor-peptider, der regulerer patologiske permeabilitetsændringer
KR1019980701343A KR100552947B1 (ko) 1995-08-24 1996-08-23 병리적투과성변화를조절하는항분비인자펩티드
AU68932/96A AU702589B2 (en) 1995-08-24 1996-08-23 Antisecretory factor peptides regulating pathological permeability changes
CNB961973005A CN1171902C (zh) 1995-08-24 1996-08-23 调节病理通透性改变的抑制分泌因子肽
SI9630013T SI0851876T1 (en) 1995-08-24 1996-08-23 Antisecretory factor peptides regulating pathological permeability changes
PT96929619T PT851876E (pt) 1995-08-24 1996-08-23 Peptido factor anti-secretorio regulador das alteracoes patologicas da permeabilidade
RO98-00364A RO120197B1 (ro) 1995-08-24 1996-08-23 Factori antisecreţionali, pentru reglarea schimbării permeabilităţii patologice
HU9900137A HU224971B1 (en) 1995-08-24 1996-08-23 Antisecretory factor peptides regulating pathological permeability changes
NZ316647A NZ316647A (en) 1995-08-24 1996-08-23 Antisecretory recombinant peptides regulating fluid transport and inflammatory reactions and uses thereof
SK236-98A SK23698A3 (en) 1995-08-24 1996-08-23 Antisecretory factor peptides regulating pathological permeability changes
US09/029,333 US6344440B1 (en) 1995-08-24 1996-08-23 Antisecretory factor peptides regulating pathological permeability changes
ES96929619T ES2118683T3 (es) 1995-08-24 1996-08-23 Peptidos del factor antisecretor que regulan las modificaciones patologicas de permeabilidad.
IL15290996A IL152909A0 (en) 1995-08-24 1996-08-23 Antisecretory factor peptides regulating pathological permeability changes
CA2230111A CA2230111C (en) 1995-08-24 1996-08-23 Antisecretory factor peptides regulating pathological permeability changes
DE69632828T DE69632828T2 (de) 1995-08-24 1996-08-23 Peptide des antisekretorischen faktors, welches krankhafte permeabilitätsanderungen reguliert
IL12340496A IL123404A (en) 1995-08-24 1996-08-23 Antisecretory factor peptides regulating pathological permeability changes
EP96929619A EP0851876B1 (en) 1995-08-24 1996-08-23 Antisecretory factor peptides regulating pathological permeability changes
NO19980743A NO320560B1 (no) 1995-08-24 1998-02-23 Antisekretoriske faktorpeptider som regulerer patologiske permeabilitetsforandringer, samt formateriale som omfatter disse.
BG102280A BG63209B1 (bg) 1995-08-24 1998-02-24 Пептиди на антисекреторен фактор регулиращи паталогичните промени на пропускливост
HK99103574A HK1018468A1 (en) 1995-08-24 1999-08-17 Antisecretory factor peptides regulating pathological permeability changes.
NZ337380A NZ337380A (en) 1995-08-24 1999-08-20 Use of antisecretory factor peptides for regulating pathological permeability changes
US09/991,792 US20020099016A1 (en) 1995-08-24 2001-11-26 Antisecretory factor peptides regulating pathological permeability changes
JP2007193054A JP2008043331A (ja) 1995-08-24 2007-07-25 病理学的浸透性の変化を調節する抗分泌性因子ペプチド

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9502936A SE508609C2 (sv) 1995-08-24 1995-08-24 Antisekretorisk faktor - dess aminosyrasekvens, nubleinsyrasekvens och användning

Publications (3)

Publication Number Publication Date
SE9502936D0 SE9502936D0 (sv) 1995-08-24
SE9502936L true SE9502936L (sv) 1997-02-25
SE508609C2 SE508609C2 (sv) 1998-10-19

Family

ID=20399269

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9502936A SE508609C2 (sv) 1995-08-24 1995-08-24 Antisekretorisk faktor - dess aminosyrasekvens, nubleinsyrasekvens och användning

Country Status (29)

Country Link
US (2) US6344440B1 (sv)
EP (1) EP0851876B1 (sv)
JP (2) JP4040679B2 (sv)
KR (1) KR100552947B1 (sv)
CN (1) CN1171902C (sv)
AT (1) ATE270305T1 (sv)
AU (1) AU702589B2 (sv)
BG (1) BG63209B1 (sv)
BR (1) BR9610308A (sv)
CA (1) CA2230111C (sv)
CZ (1) CZ295444B6 (sv)
DE (2) DE69632828T2 (sv)
DK (1) DK0851876T3 (sv)
EA (1) EA001201B1 (sv)
EE (1) EE04501B1 (sv)
ES (1) ES2118683T3 (sv)
HK (1) HK1018468A1 (sv)
HU (1) HU224971B1 (sv)
IL (1) IL123404A (sv)
NO (1) NO320560B1 (sv)
NZ (2) NZ316647A (sv)
PL (1) PL188530B1 (sv)
PT (1) PT851876E (sv)
RO (1) RO120197B1 (sv)
SE (1) SE508609C2 (sv)
SI (1) SI0851876T1 (sv)
SK (1) SK23698A3 (sv)
TR (1) TR199800304T1 (sv)
WO (1) WO1997008202A1 (sv)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE508609C2 (sv) * 1995-08-24 1998-10-19 Rural Patent Svenska Ab Antisekretorisk faktor - dess aminosyrasekvens, nubleinsyrasekvens och användning
SE9604251L (sv) * 1996-11-20 1997-12-22 Svenska Lantmaennen Riksfoerbu Födoämne som vid förtäring inducerar antisekretoriska proteiner
SE513496C2 (sv) 1998-12-17 2000-09-18 Rural Patent Svenska Ab NASP-berikad äggula samt dess användning
EP1109900A1 (en) * 1999-06-21 2001-06-27 Inkine Pharmaceutical Company Inc. Angiocidin: a cys-ser-val-thr-cys-gly specific tumor cell adhesion receptor
GB0322645D0 (en) * 2003-09-26 2003-10-29 Melacure Therapeutics Ab Use of antisecretory factor peptides
KR20090037992A (ko) 2006-04-27 2009-04-17 란트만넨 아스-팍토르 아베 항분비 단백질의 추가적 의학 용도
ATE526031T1 (de) * 2006-04-27 2011-10-15 Lantmaennen As Faktor Ab Antisekretorisches protein zur verwendung bei der behandung von kompartiment-syndrom
RU2458703C2 (ru) * 2006-04-27 2012-08-20 Лантменнен Ас-Фактор Новый подход к лечению повышенного внутриглазного давления
US8901083B2 (en) 2008-11-25 2014-12-02 Temple University Administration of angiocidin for the treatment of leukemia
EP3769778A1 (en) 2009-02-11 2021-01-27 Lantmännen Medical AB Use of antisecretory factors (af) for optimizing cellular uptake
CN107949392B (zh) * 2015-07-10 2022-10-11 兰特门内阿斯-法克托尔公司 用于生产含高含量af-16的蛋黄的方法
EP3484909B1 (en) 2016-07-18 2021-06-16 Lantmännen Medical AB Antisecretory factor 17
CA3103164A1 (en) 2018-06-28 2020-01-02 Lantmannen Medical Ab Antisecretory factor for use in treatment and/or prevention of acute respiratory failure
EP3855934A2 (en) * 2018-09-28 2021-08-04 Lantmännen Functional Foods AB A consumable product comprising malted dehulled oat
WO2020065091A1 (en) 2018-09-28 2020-04-02 Lantmännen Functional Foods Ab A consumable product comprising malted wheat
JP2023518790A (ja) 2020-03-26 2023-05-08 ラントメネン・ファンクショナル・フーズ・アーベー 身体活動時の回復を促進するための麦芽穀類を含む消費可能な製品

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE508609C2 (sv) * 1995-08-24 1998-10-19 Rural Patent Svenska Ab Antisekretorisk faktor - dess aminosyrasekvens, nubleinsyrasekvens och användning

Also Published As

Publication number Publication date
EE9800055A (et) 1998-08-17
HK1018468A1 (en) 1999-12-24
NO980743D0 (no) 1998-02-23
SE508609C2 (sv) 1998-10-19
PL325114A1 (en) 1998-07-06
KR19990044110A (ko) 1999-06-25
KR100552947B1 (ko) 2006-04-21
SK23698A3 (en) 1998-12-02
CN1171902C (zh) 2004-10-20
NZ337380A (en) 2001-02-23
CA2230111C (en) 2012-10-30
CZ295444B6 (cs) 2005-08-17
HUP9900137A3 (en) 1999-11-29
JP2008043331A (ja) 2008-02-28
JP4040679B2 (ja) 2008-01-30
WO1997008202A1 (en) 1997-03-06
CN1208420A (zh) 1999-02-17
PT851876E (pt) 2004-10-29
RO120197B1 (ro) 2005-10-28
NO980743L (no) 1998-04-16
DE851876T1 (de) 1998-11-12
EA199800221A1 (ru) 1998-10-29
CA2230111A1 (en) 1997-03-06
JPH11511972A (ja) 1999-10-19
AU702589B2 (en) 1999-02-25
ES2118683T1 (es) 1998-10-01
EP0851876A1 (en) 1998-07-08
DK0851876T3 (da) 2004-10-25
ATE270305T1 (de) 2004-07-15
EP0851876B1 (en) 2004-06-30
IL123404A0 (en) 1998-09-24
DE69632828T2 (de) 2005-07-14
CZ52098A3 (cs) 1998-09-16
SI0851876T1 (en) 2004-10-31
US6344440B1 (en) 2002-02-05
EE04501B1 (et) 2005-06-15
EA001201B1 (ru) 2000-12-25
AU6893296A (en) 1997-03-19
HU224971B1 (en) 2006-04-28
HUP9900137A2 (hu) 1999-04-28
PL188530B1 (pl) 2005-02-28
BR9610308A (pt) 1999-12-21
NO320560B1 (no) 2005-12-19
IL123404A (en) 2005-07-25
NZ316647A (en) 1999-10-28
SE9502936D0 (sv) 1995-08-24
BG63209B1 (bg) 2001-06-29
DE69632828D1 (de) 2004-08-05
ES2118683T3 (es) 2004-12-01
US20020099016A1 (en) 2002-07-25
TR199800304T1 (xx) 1998-05-21
BG102280A (en) 1999-04-30

Similar Documents

Publication Publication Date Title
SE9502936L (sv) Antisekretorisk faktor-proteiner som reglerar förändringar i tarmpermeabilitet
Fullmer et al. Bovine intestinal calcium-binding proteins: Purification and some properties
EA200000216A1 (ru) Белки, связывающие интерлейкин-18, их получение и применение
DE69534235D1 (de) Cytokin lerk-7
PT101297A (pt) Factores mitogenicos gliais, sua preparacao e utilizacao
NO990086L (no) Avkortete, l°selige tumornekrosefaktorreseptorer av type I og type II
DE3786592D1 (de) Transformation von trichoderma.
DK555082A (da) B.thuringiensis krystalprotein i e.coli.
DK1482040T3 (da) NL3-TIE-receptortyrosinkinaseligandhomologer
ES2085993T3 (es) Proteina asociada a la pancreatitis aguda, medios para el diagnostico de la pancreatitis aguda.
ATE242323T1 (de) Transportprotein, das den transport von kationischen xenobiotika und/oder pharmaka bewirkt, dafür kodierende dna-sequenzen und deren verwendung
WO2003065003A3 (en) Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
DE68925869D1 (de) Modifizierte Proteine, modifizierte Interferone alpha- und beta-phosphorylierte Proteine, DNA-Sequenzen und Analoge und deren Verwendung
DK0901526T3 (da) Cortistatin: neuropeptider, sammensætninger og metoder
DE68925275D1 (de) Endotoxin-bindeprotein und dessen verwendung
MX24651A (es) Compuestos de adn recombinante, vectores de expresion de mutantes de glicosilacion de la proteina c humana, celulas huesped transformadas y metodo para la produccion recombinante de formas zimogenas de proteina c humana.
DE3688974D1 (de) Expressionssysteme zur überproduktion gewünschter proteine.
ATE45067T1 (de) Eiweisshydrolysat.

Legal Events

Date Code Title Description
NUG Patent has lapsed